Gavin Newsom’s ambitious plan to produce a cheap ... has not started clinical trials or applied for approval from the federal Food and Drug Administration, both of which are likely to take more than a year to complete. During his 2023 State of the ...
Although California's governor hoped to have the cheaper insulin available by last year, it may take at least another two years.
California Gov. Gavin Newsom (D) said he looks forward to President Trump visiting Los Angeles and stands “ready to work” with his administration on issues on which their values align.
Welcome to CalMatters, the only nonprofit newsroom devoted solely to covering issues that affect all Californians. Sign up for WhatMatters to receive the latest news and commentary on the most ...
Click to share on X (Opens in new window) Click to share on Facebook (Opens in new window) Click to print (Opens in new window) Click to email a link to a friend (Opens in new window) Gov.
Gov. Gavin Newsom faces what may be his greatest political test and leadership challenge. He planned to greet President Trump upon his arrival in Southern California on Friday.
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced
Trump is set to visit California on Friday, and the state’s governor will need to convince the president and congressional Republicans to provide aid to help rebuild Los Angeles.
The Trump administration's "short pause" on communications, expected to end on Feb. 1, has affected FDA updates on food contamination investigations.
The Trump administration’s freeze on communications from U.S. health agencies is leading to another disruption: the abrupt cancellation of scientific meetings. The move covers a swath of health conditions,
President Trump announced he's pulling the U.S. from the WHO. Now researchers are scrambling to understand what that means for the H5N1 bird flu pandemic.
Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has instructed the heads of every federal health agency to stop public communication, The Washington Post reported.